Physician profile
Whitney Paige Wagner
NPI 1316691462
$474.94
in general payments reported to CMS, 2019-2025
10 companies · $218 in 2025
The $218 reported for 2025 was more than what 81% of Pediatrics, Critical Care providers received nationally (typical 2025 total: $80.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $74.43 · 2024: $183 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $106.98 | 2025 | Entyvio, Gattex, Eohilia |
| Lilly USA, LLC | $78.75 | 2023-2025 | Omvoh, Jardiance, Zepbound |
| Novo Nordisk INC | $68.71 | 2023-2024 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $64.71 | 2025 | |
| Medtronic, INC. | $39.32 | 2024 | Intellis Adaptivestim |
| Glaxosmithkline, LLC. | $34.26 | 2024 | Trelegy Ellipta, Shingrix |
| Sanofi-Aventis U.S. LLC | $33.38 | 2024 | |
| Qol Medical, LLC | $21.65 | 2025 | Sucraid |
| Shield Therapeutics INC | $13.65 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $13.53 | 2023 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.